世界の腫瘍ラジオ波焼灼療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Tumor Radiofrequency Ablation Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6056 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、腫瘍ラジオ波焼灼療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、腎臓がん、乳がん、前立腺がん、肝臓がん、その他）、用途別市場規模（病院、がん専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・腫瘍ラジオ波焼灼療法の市場動向 ・企業の競争状況、市場シェア ・腫瘍ラジオ波焼灼療法の種類別市場規模と予測2016-2027（肺がん、腎臓がん、乳がん、前立腺がん、肝臓がん、その他） ・腫瘍ラジオ波焼灼療法の用途別市場規模と予測2016-2027（病院、がん専門クリニック、その他） ・腫瘍ラジオ波焼灼療法の北米市場規模2016-2027（アメリカ、カナダ） ・腫瘍ラジオ波焼灼療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・腫瘍ラジオ波焼灼療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腫瘍ラジオ波焼灼療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・腫瘍ラジオ波焼灼療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Boston Scientific、Diros Technology、Halyard Health、St. Jude Medical、Cosman Medical、Medtronic、NeuroTherm、Stryker、Cosman Medical） ・結論

Radiofrequency ablation (or RFA) is a procedure used to reduce pain. An electrical current produced by a radio wave is used to heat up a small area of nerve tissue, thereby decreasing pain signals from that specific area.

Market Analysis and Insights: Global Tumor Radiofrequency Ablation Market
The global Tumor Radiofrequency Ablation market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tumor Radiofrequency Ablation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tumor Radiofrequency Ablation market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tumor Radiofrequency Ablation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tumor Radiofrequency Ablation market.

Global Tumor Radiofrequency Ablation Scope and Market Size
Tumor Radiofrequency Ablation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Radiofrequency Ablation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Lung Cancer
Kidney Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Others

Segment by Application
Hospitals
Cancer Specialty Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Boston Scientific
Diros Technology
Halyard Health
St. Jude Medical
Cosman Medical
Medtronic
NeuroTherm
Stryker
Cosman Medical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Radiofrequency Ablation Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Lung Cancer
1.2.3 Kidney Cancer
1.2.4 Breast Cancer
1.2.5 Prostate Cancer
1.2.6 Liver Cancer
1.2.7 Others
1.3 Market by Application
1.3.1 Global Tumor Radiofrequency Ablation Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Cancer Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Tumor Radiofrequency Ablation Market Perspective (2016-2027)
2.2 Tumor Radiofrequency Ablation Growth Trends by Regions
2.2.1 Tumor Radiofrequency Ablation Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tumor Radiofrequency Ablation Historic Market Share by Regions (2016-2021)
2.2.3 Tumor Radiofrequency Ablation Forecasted Market Size by Regions (2022-2027)
2.3 Tumor Radiofrequency Ablation Industry Dynamic
2.3.1 Tumor Radiofrequency Ablation Market Trends
2.3.2 Tumor Radiofrequency Ablation Market Drivers
2.3.3 Tumor Radiofrequency Ablation Market Challenges
2.3.4 Tumor Radiofrequency Ablation Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Tumor Radiofrequency Ablation Players by Revenue
3.1.1 Global Top Tumor Radiofrequency Ablation Players by Revenue (2016-2021)
3.1.2 Global Tumor Radiofrequency Ablation Revenue Market Share by Players (2016-2021)
3.2 Global Tumor Radiofrequency Ablation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tumor Radiofrequency Ablation Revenue
3.4 Global Tumor Radiofrequency Ablation Market Concentration Ratio
3.4.1 Global Tumor Radiofrequency Ablation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Radiofrequency Ablation Revenue in 2020
3.5 Tumor Radiofrequency Ablation Key Players Head office and Area Served
3.6 Key Players Tumor Radiofrequency Ablation Product Solution and Service
3.7 Date of Enter into Tumor Radiofrequency Ablation Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Tumor Radiofrequency Ablation Breakdown Data by Type
4.1 Global Tumor Radiofrequency Ablation Historic Market Size by Type (2016-2021)
4.2 Global Tumor Radiofrequency Ablation Forecasted Market Size by Type (2022-2027)

5 Tumor Radiofrequency Ablation Breakdown Data by Application
5.1 Global Tumor Radiofrequency Ablation Historic Market Size by Application (2016-2021)
5.2 Global Tumor Radiofrequency Ablation Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Tumor Radiofrequency Ablation Market Size (2016-2027)
6.2 North America Tumor Radiofrequency Ablation Market Size by Type
6.2.1 North America Tumor Radiofrequency Ablation Market Size by Type (2016-2021)
6.2.2 North America Tumor Radiofrequency Ablation Market Size by Type (2022-2027)
6.2.3 North America Tumor Radiofrequency Ablation Market Size by Type (2016-2027)
6.3 North America Tumor Radiofrequency Ablation Market Size by Application
6.3.1 North America Tumor Radiofrequency Ablation Market Size by Application (2016-2021)
6.3.2 North America Tumor Radiofrequency Ablation Market Size by Application (2022-2027)
6.3.3 North America Tumor Radiofrequency Ablation Market Size by Application (2016-2027)
6.4 North America Tumor Radiofrequency Ablation Market Size by Country
6.4.1 North America Tumor Radiofrequency Ablation Market Size by Country (2016-2021)
6.4.2 North America Tumor Radiofrequency Ablation Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Tumor Radiofrequency Ablation Market Size (2016-2027)
7.2 Europe Tumor Radiofrequency Ablation Market Size by Type
7.2.1 Europe Tumor Radiofrequency Ablation Market Size by Type (2016-2021)
7.2.2 Europe Tumor Radiofrequency Ablation Market Size by Type (2022-2027)
7.2.3 Europe Tumor Radiofrequency Ablation Market Size by Type (2016-2027)
7.3 Europe Tumor Radiofrequency Ablation Market Size by Application
7.3.1 Europe Tumor Radiofrequency Ablation Market Size by Application (2016-2021)
7.3.2 Europe Tumor Radiofrequency Ablation Market Size by Application (2022-2027)
7.3.3 Europe Tumor Radiofrequency Ablation Market Size by Application (2016-2027)
7.4 Europe Tumor Radiofrequency Ablation Market Size by Country
7.4.1 Europe Tumor Radiofrequency Ablation Market Size by Country (2016-2021)
7.4.2 Europe Tumor Radiofrequency Ablation Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Tumor Radiofrequency Ablation Market Size (2016-2027)
8.2 Asia-Pacific Tumor Radiofrequency Ablation Market Size by Type
8.2.1 Asia-Pacific Tumor Radiofrequency Ablation Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tumor Radiofrequency Ablation Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tumor Radiofrequency Ablation Market Size by Type (2016-2027)
8.3 Asia-Pacific Tumor Radiofrequency Ablation Market Size by Application
8.3.1 Asia-Pacific Tumor Radiofrequency Ablation Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tumor Radiofrequency Ablation Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tumor Radiofrequency Ablation Market Size by Application (2016-2027)
8.4 Asia-Pacific Tumor Radiofrequency Ablation Market Size by Region
8.4.1 Asia-Pacific Tumor Radiofrequency Ablation Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tumor Radiofrequency Ablation Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Tumor Radiofrequency Ablation Market Size (2016-2027)
9.2 Latin America Tumor Radiofrequency Ablation Market Size by Type
9.2.1 Latin America Tumor Radiofrequency Ablation Market Size by Type (2016-2021)
9.2.2 Latin America Tumor Radiofrequency Ablation Market Size by Type (2022-2027)
9.2.3 Latin America Tumor Radiofrequency Ablation Market Size by Type (2016-2027)
9.3 Latin America Tumor Radiofrequency Ablation Market Size by Application
9.3.1 Latin America Tumor Radiofrequency Ablation Market Size by Application (2016-2021)
9.3.2 Latin America Tumor Radiofrequency Ablation Market Size by Application (2022-2027)
9.3.3 Latin America Tumor Radiofrequency Ablation Market Size by Application (2016-2027)
9.4 Latin America Tumor Radiofrequency Ablation Market Size by Country
9.4.1 Latin America Tumor Radiofrequency Ablation Market Size by Country (2016-2021)
9.4.2 Latin America Tumor Radiofrequency Ablation Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Tumor Radiofrequency Ablation Market Size (2016-2027)
10.2 Middle East & Africa Tumor Radiofrequency Ablation Market Size by Type
10.2.1 Middle East & Africa Tumor Radiofrequency Ablation Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tumor Radiofrequency Ablation Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tumor Radiofrequency Ablation Market Size by Type (2016-2027)
10.3 Middle East & Africa Tumor Radiofrequency Ablation Market Size by Application
10.3.1 Middle East & Africa Tumor Radiofrequency Ablation Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tumor Radiofrequency Ablation Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tumor Radiofrequency Ablation Market Size by Application (2016-2027)
10.4 Middle East & Africa Tumor Radiofrequency Ablation Market Size by Country
10.4.1 Middle East & Africa Tumor Radiofrequency Ablation Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tumor Radiofrequency Ablation Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Boston Scientific
11.1.1 Boston Scientific Company Details
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific Tumor Radiofrequency Ablation Introduction
11.1.4 Boston Scientific Revenue in Tumor Radiofrequency Ablation Business (2016-2021)
11.1.5 Boston Scientific Recent Development
11.2 Diros Technology
11.2.1 Diros Technology Company Details
11.2.2 Diros Technology Business Overview
11.2.3 Diros Technology Tumor Radiofrequency Ablation Introduction
11.2.4 Diros Technology Revenue in Tumor Radiofrequency Ablation Business (2016-2021)
11.2.5 Diros Technology Recent Development
11.3 Halyard Health
11.3.1 Halyard Health Company Details
11.3.2 Halyard Health Business Overview
11.3.3 Halyard Health Tumor Radiofrequency Ablation Introduction
11.3.4 Halyard Health Revenue in Tumor Radiofrequency Ablation Business (2016-2021)
11.3.5 Halyard Health Recent Development
11.4 St. Jude Medical
11.4.1 St. Jude Medical Company Details
11.4.2 St. Jude Medical Business Overview
11.4.3 St. Jude Medical Tumor Radiofrequency Ablation Introduction
11.4.4 St. Jude Medical Revenue in Tumor Radiofrequency Ablation Business (2016-2021)
11.4.5 St. Jude Medical Recent Development
11.5 Cosman Medical
11.5.1 Cosman Medical Company Details
11.5.2 Cosman Medical Business Overview
11.5.3 Cosman Medical Tumor Radiofrequency Ablation Introduction
11.5.4 Cosman Medical Revenue in Tumor Radiofrequency Ablation Business (2016-2021)
11.5.5 Cosman Medical Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Details
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Tumor Radiofrequency Ablation Introduction
11.6.4 Medtronic Revenue in Tumor Radiofrequency Ablation Business (2016-2021)
11.6.5 Medtronic Recent Development
11.7 NeuroTherm
11.7.1 NeuroTherm Company Details
11.7.2 NeuroTherm Business Overview
11.7.3 NeuroTherm Tumor Radiofrequency Ablation Introduction
11.7.4 NeuroTherm Revenue in Tumor Radiofrequency Ablation Business (2016-2021)
11.7.5 NeuroTherm Recent Development
11.8 Stryker
11.8.1 Stryker Company Details
11.8.2 Stryker Business Overview
11.8.3 Stryker Tumor Radiofrequency Ablation Introduction
11.8.4 Stryker Revenue in Tumor Radiofrequency Ablation Business (2016-2021)
11.8.5 Stryker Recent Development
11.9 Cosman Medical
11.9.1 Cosman Medical Company Details
11.9.2 Cosman Medical Business Overview
11.9.3 Cosman Medical Tumor Radiofrequency Ablation Introduction
11.9.4 Cosman Medical Revenue in Tumor Radiofrequency Ablation Business (2016-2021)
11.9.5 Cosman Medical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Tumor Radiofrequency Ablation Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Lung Cancer
Table 3. Key Players of Kidney Cancer
Table 4. Key Players of Breast Cancer
Table 5. Key Players of Prostate Cancer
Table 6. Key Players of Liver Cancer
Table 7. Key Players of Others
Table 8. Global Tumor Radiofrequency Ablation Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Tumor Radiofrequency Ablation Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Tumor Radiofrequency Ablation Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Tumor Radiofrequency Ablation Market Share by Regions (2016-2021)
Table 12. Global Tumor Radiofrequency Ablation Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Tumor Radiofrequency Ablation Market Share by Regions (2022-2027)
Table 14. Tumor Radiofrequency Ablation Market Trends
Table 15. Tumor Radiofrequency Ablation Market Drivers
Table 16. Tumor Radiofrequency Ablation Market Challenges
Table 17. Tumor Radiofrequency Ablation Market Restraints
Table 18. Global Tumor Radiofrequency Ablation Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Tumor Radiofrequency Ablation Market Share by Players (2016-2021)
Table 20. Global Top Tumor Radiofrequency Ablation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Radiofrequency Ablation as of 2020)
Table 21. Ranking of Global Top Tumor Radiofrequency Ablation Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Tumor Radiofrequency Ablation Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Tumor Radiofrequency Ablation Product Solution and Service
Table 25. Date of Enter into Tumor Radiofrequency Ablation Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Tumor Radiofrequency Ablation Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Tumor Radiofrequency Ablation Revenue Market Share by Type (2016-2021)
Table 29. Global Tumor Radiofrequency Ablation Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Tumor Radiofrequency Ablation Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Tumor Radiofrequency Ablation Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Tumor Radiofrequency Ablation Revenue Market Share by Application (2016-2021)
Table 33. Global Tumor Radiofrequency Ablation Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Tumor Radiofrequency Ablation Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Tumor Radiofrequency Ablation Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Tumor Radiofrequency Ablation Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Tumor Radiofrequency Ablation Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Tumor Radiofrequency Ablation Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Tumor Radiofrequency Ablation Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Tumor Radiofrequency Ablation Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Tumor Radiofrequency Ablation Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Tumor Radiofrequency Ablation Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Tumor Radiofrequency Ablation Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Tumor Radiofrequency Ablation Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Tumor Radiofrequency Ablation Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Tumor Radiofrequency Ablation Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Tumor Radiofrequency Ablation Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Tumor Radiofrequency Ablation Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Tumor Radiofrequency Ablation Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Tumor Radiofrequency Ablation Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Tumor Radiofrequency Ablation Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Tumor Radiofrequency Ablation Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Tumor Radiofrequency Ablation Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Tumor Radiofrequency Ablation Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Tumor Radiofrequency Ablation Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Tumor Radiofrequency Ablation Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Tumor Radiofrequency Ablation Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Tumor Radiofrequency Ablation Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Tumor Radiofrequency Ablation Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Tumor Radiofrequency Ablation Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Tumor Radiofrequency Ablation Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Tumor Radiofrequency Ablation Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Tumor Radiofrequency Ablation Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Tumor Radiofrequency Ablation Market Size by Country (2022-2027) & (US$ Million)
Table 65. Boston Scientific Company Details
Table 66. Boston Scientific Business Overview
Table 67. Boston Scientific Tumor Radiofrequency Ablation Product
Table 68. Boston Scientific Revenue in Tumor Radiofrequency Ablation Business (2016-2021) & (US$ Million)
Table 69. Boston Scientific Recent Development
Table 70. Diros Technology Company Details
Table 71. Diros Technology Business Overview
Table 72. Diros Technology Tumor Radiofrequency Ablation Product
Table 73. Diros Technology Revenue in Tumor Radiofrequency Ablation Business (2016-2021) & (US$ Million)
Table 74. Diros Technology Recent Development
Table 75. Halyard Health Company Details
Table 76. Halyard Health Business Overview
Table 77. Halyard Health Tumor Radiofrequency Ablation Product
Table 78. Halyard Health Revenue in Tumor Radiofrequency Ablation Business (2016-2021) & (US$ Million)
Table 79. Halyard Health Recent Development
Table 80. St. Jude Medical Company Details
Table 81. St. Jude Medical Business Overview
Table 82. St. Jude Medical Tumor Radiofrequency Ablation Product
Table 83. St. Jude Medical Revenue in Tumor Radiofrequency Ablation Business (2016-2021) & (US$ Million)
Table 84. St. Jude Medical Recent Development
Table 85. Cosman Medical Company Details
Table 86. Cosman Medical Business Overview
Table 87. Cosman Medical Tumor Radiofrequency Ablation Product
Table 88. Cosman Medical Revenue in Tumor Radiofrequency Ablation Business (2016-2021) & (US$ Million)
Table 89. Cosman Medical Recent Development
Table 90. Medtronic Company Details
Table 91. Medtronic Business Overview
Table 92. Medtronic Tumor Radiofrequency Ablation Product
Table 93. Medtronic Revenue in Tumor Radiofrequency Ablation Business (2016-2021) & (US$ Million)
Table 94. Medtronic Recent Development
Table 95. NeuroTherm Company Details
Table 96. NeuroTherm Business Overview
Table 97. NeuroTherm Tumor Radiofrequency Ablation Product
Table 98. NeuroTherm Revenue in Tumor Radiofrequency Ablation Business (2016-2021) & (US$ Million)
Table 99. NeuroTherm Recent Development
Table 100. Stryker Company Details
Table 101. Stryker Business Overview
Table 102. Stryker Revenue in Tumor Radiofrequency Ablation Business (2016-2021) & (US$ Million)
Table 103. Stryker Recent Development
Table 104. Cosman Medical Company Details
Table 105. Cosman Medical Business Overview
Table 106. Cosman Medical Tumor Radiofrequency Ablation Product
Table 107. Cosman Medical Revenue in Tumor Radiofrequency Ablation Business (2016-2021) & (US$ Million)
Table 108. Cosman Medical Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor Radiofrequency Ablation Market Share by Type: 2020 VS 2027
Figure 2. Lung Cancer Features
Figure 3. Kidney Cancer Features
Figure 4. Breast Cancer Features
Figure 5. Prostate Cancer Features
Figure 6. Liver Cancer Features
Figure 7. Others Features
Figure 8. Global Tumor Radiofrequency Ablation Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Cancer Specialty Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Tumor Radiofrequency Ablation Report Years Considered
Figure 13. Global Tumor Radiofrequency Ablation Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Tumor Radiofrequency Ablation Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Tumor Radiofrequency Ablation Market Share by Regions: 2020 VS 2027
Figure 16. Global Tumor Radiofrequency Ablation Market Share by Regions (2022-2027)
Figure 17. Global Tumor Radiofrequency Ablation Market Share by Players in 2020
Figure 18. Global Top Tumor Radiofrequency Ablation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Radiofrequency Ablation as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Tumor Radiofrequency Ablation Revenue in 2020
Figure 20. Global Tumor Radiofrequency Ablation Revenue Market Share by Type (2016-2021)
Figure 21. Global Tumor Radiofrequency Ablation Revenue Market Share by Type (2022-2027)
Figure 22. North America Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Tumor Radiofrequency Ablation Market Share by Type (2016-2027)
Figure 24. North America Tumor Radiofrequency Ablation Market Share by Application (2016-2027)
Figure 25. North America Tumor Radiofrequency Ablation Market Share by Country (2016-2027)
Figure 26. United States Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Tumor Radiofrequency Ablation Market Share by Type (2016-2027)
Figure 30. Europe Tumor Radiofrequency Ablation Market Share by Application (2016-2027)
Figure 31. Europe Tumor Radiofrequency Ablation Market Share by Country (2016-2027)
Figure 32. Germany Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Tumor Radiofrequency Ablation Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Tumor Radiofrequency Ablation Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Tumor Radiofrequency Ablation Market Share by Region (2016-2027)
Figure 42. China Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Tumor Radiofrequency Ablation Market Share by Type (2016-2027)
Figure 50. Latin America Tumor Radiofrequency Ablation Market Share by Application (2016-2027)
Figure 51. Latin America Tumor Radiofrequency Ablation Market Share by Country (2016-2027)
Figure 52. Mexico Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Tumor Radiofrequency Ablation Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Tumor Radiofrequency Ablation Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Tumor Radiofrequency Ablation Market Share by Country (2016-2027)
Figure 58. Turkey Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Tumor Radiofrequency Ablation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Boston Scientific Revenue Growth Rate in Tumor Radiofrequency Ablation Business (2016-2021)
Figure 62. Diros Technology Revenue Growth Rate in Tumor Radiofrequency Ablation Business (2016-2021)
Figure 63. Halyard Health Revenue Growth Rate in Tumor Radiofrequency Ablation Business (2016-2021)
Figure 64. St. Jude Medical Revenue Growth Rate in Tumor Radiofrequency Ablation Business (2016-2021)
Figure 65. Cosman Medical Revenue Growth Rate in Tumor Radiofrequency Ablation Business (2016-2021)
Figure 66. Medtronic Revenue Growth Rate in Tumor Radiofrequency Ablation Business (2016-2021)
Figure 67. NeuroTherm Revenue Growth Rate in Tumor Radiofrequency Ablation Business (2016-2021)
Figure 68. Stryker Revenue Growth Rate in Tumor Radiofrequency Ablation Business (2016-2021)
Figure 69. Cosman Medical Revenue Growth Rate in Tumor Radiofrequency Ablation Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---